NL-OMON40227招募中不适用
The effect of IL-1 inhibition by anakinra in acute gout;- A proof of concept study- - The effect of IL-1 inhibition by anakinra in acute gout
Jan van Breemen Instituut0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with a crystal-confirmed diagnosis of gout
- •Patients with known intolerance or contra-indications for colchicine and NSAIDs and relative contra-indications to systemic prednisolone.
- •Patients with a currently acute gout flare
排除标准
- •Patients with latent (or active) tuberculosis,
- •Positive serology for hepatitis B or C,
- •Patients with diabetes mellitus,
- •Patients with an extended history of cardiovascular disease
- •Patients s with a creatinine clearance less than 30 ml/min
- •Patients willing to receive an standard treatment conform the ACR guidelines 2012 and who do not agree to participate in the study
研究者
相似试验
进行中（未招募）
不适用
Anakinra to treat a gout attackEUCTR2014-000173-39-NLJan van Breemen Research Institute Reade and VU University Medical Centre
已完成
不适用
Effect of anakinra (soluble interleukin-1 receptor antagonist) as combination therapy: second UK combination therapy in early rheumatoid arthritisMusculoskeletal DiseasesRheumatoid arthritisISRCTN15819795King's College London (UK)158
进行中（未招募）
1 期
Anakinra as prevention of fever and mucositis in patients with a stem cell transplantatioFebrile neutropenia and mucositisMedDRA version: 20.0Level: LLTClassification code 10028127Term: MucositisSystem Organ Class: 100000004867MedDRA version: 20.0Level: PTClassification code 10016288Term: Febrile neutropeniaSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2018-005046-10-NLRadboud university medical center90
招募中
2 期
Anakinra: safety and efficacy of interleukin-1 pathway inhibitor anakinra for the management of fever during neutropenia and mucositis in patients with multiple myeloma receiving an autologous hematopoietic stem cell transplantation after high-dose melphalan - A randomized controlled trialand fever during neutropenia)mucositis and febrile neutropenia(inflammation of the lining of the digestive system100188651001796910005908NL-OMON48856Radboud Universitair Medisch Centrum90
已完成
不适用
Effect of Interleukin-1 receptor antagonist on insulin sensitivity in obese, insulin resistant individualsmaturity-onset diabetestype 2 diabetes mellitus10018424NL-OMON33714niversitair Medisch Centrum Sint Radboud12